Poudyal H, Panchal SK, Ward LC, Waanders J, Brown L. Chronic high-carbohydrate, high-fat feeding in rats induces reversible metabolic, cardiovascular, and liver changes. Am J Physiol Endocrinol Metab 302: E1472-E1482, 2012. First published March 20, 2012 doi:10.1152/ajpendo.00102.2012.-Age-related physiological changes develop at the same time as the increase in metabolic syndrome in humans after young adulthood. There is a paucity of data in models mimicking chronic diet-induced changes in human middle age and interventions to reverse these changes. This study measured the changes during chronic consumption of a high-carbohydrate (as cornstarch), low-fat (C) diet and a high-carbohydrate (as fructose and sucrose), high-fat (H) diet in rats for 32 wk. C diet feeding induced changes without metabolic syndrome, such as disproportionate increases in total body lean and fat mass, reduced bone mineral content, cardiovascular remodeling with increased systolic blood pressure, left ventricular and arterial stiffness, and increased plasma markers of liver injury. H diet feeding induced visceral adiposity with reduced lean mass, increased lipid infiltration in the skeletal muscle, impaired glucose and insulin tolerance, cardiovascular remodeling, hepatic steatosis, and increased infiltration of inflammatory cells in the heart and the liver. Chia seed supplementation for 24 wk attenuated most structural and functional modifications induced by age or H diet, including increased whole body lean mass and lipid redistribution from the abdominal area, and normalized the chronic low-grade inflammation induced by H diet feeding; these effects may be mediated by increased metabolism of anti-inflammatory n-3 fatty acids from chia seed. These results suggest that chronic H diet feeding for 32 wk mimics the diet-induced cardiovascular and metabolic changes in middle age and that chia seed may serve as an alternative dietary strategy in the management of these changes. obesity; chia seed; omega-3 fatty acids; metabolic syndrome METABOLIC SYNDROME is defined as a cluster of risk factors, including type 2 diabetes mellitus, hypertension, dyslipidemia, and central obesity, leading to cardiovascular diseases (3). The worldwide pandemic of metabolic syndrome and, particularly, central obesity, has been attributed to increased consumption of lipogenic sugars, such as fructose, together with saturated fats (1, 37). The Western diet, characterized by excessive intake of saturated and trans fatty acids and a low n-3-to-n-6 polyunsaturated fatty acid (PUFA) ratio, has been associated with chronic diseases such as metabolic syndrome, renal diseases, and arthritis (2, 12, 24, 36) .
and middle age (9, 13, 19, 20) . Childhood or adolescent obesity is a direct cause of cardiovascular disease in young, middleaged, and elderly populations and increased all-cause mortality (25) . The progression from childhood through middle age to old age is associated with major changes in body composition, including loss of skeletal muscle mass, disproportionate decline in muscle strength, and increased abdominal fat accumulation (18) . These effects are accompanied by markedly reduced resting metabolic rate and physical activity and decreased insulin sensitivity, with a shift toward preferential oxidation of carbohydrate over fat (18) . This may lead to a sharper decline in skeletal muscle mass and characteristic lipid redistribution, with loss of subcutaneous fat and increased infiltration into lean mass, in the elderly (4, 18) .
The high global prevalence of obesity and metabolic syndrome in the Ͼ40-yr age group (14, 22, 23, 35) , coupled with age-related physiological changes, produces an intricate pathophysiology for the management of metabolic syndrome in old-age groups. Although the etiology and pathophysiology of metabolic syndrome induced by high-carbohydrate, high-fat, or a combination of both have been widely studied in animal models mimicking the young adult human condition (27) , there is a paucity of data on physiological adaptations in models mimicking the human middle age started on a high-carbohydrate, high-fat diet during adolescence or young adulthood. Understandably, such data from human studies are sparse because of the need to monitor the subjects over four decades or more.
We previously reported that the chronic changes following a high-carbohydrate (mainly fructose), high-fat (beef tallow) (H) diet for 16 wk in young male Wistar rats mimic the changes in humans, including abdominal obesity, increased total body fat mass, elevated plasma lipids and blood pressure, impaired glucose tolerance and insulin sensitivity, hepatic steatosis, and cardiovascular remodeling, compared with those following a high-carbohydrate (cornstarch), low-fat (C) diet (28) . Our previous studies showed that chia seed as a source of dietary ␣-linolenic acid (C18:3n-3) for 8 wk attenuated most risk factors of metabolic syndrome in young H diet-fed rats (32) . Chia seed supplementation induced lipid redistribution, with lipid trafficking away from the abdominal area, with increased bone mineral content, feed conversion efficiency, and total fat-free mass (32) . In this study, we have investigated the changes in body composition, fatty acid profiles of major tissues, cardiovascular remodeling, and hepatic structure and function following the administration of a C or H diet for 32 wk and the effects of chronic chia seed supplementation for the final 24 wk of either diet. These rats were ϳ10 mo of age at the end of the protocol and, therefore, could be defined as middleaged. Male Wistar rats live to ϳ27-30 mo of age (11) , and most animal houses retire male Wistar rats as breeders at ϳ10 -12 mo of age.
MATERIALS AND METHODS

Rats and diets.
The experimental groups consisted of 48 male Wistar rats (9 -10 wk old) supplied by The University of Queensland Biological Resources unit and individually housed at the University of Southern Queensland Animal House. All experimentation was approved by the Animal Experimentation Ethics Committee of the University of Southern Queensland under the guidelines of the National Health and Medical Research Council of Australia. The rats were randomly divided into four separate groups (n ϭ 12 each) and fed the C diet (335 Ϯ 1 g), the C diet ϩ chia seed (CC; 338 Ϯ 1 g), the H diet (336 Ϯ 2 g), or the H diet ϩ chia seed (HC; 333 Ϯ 2 g). All experimental groups were housed in a temperature-controlled, 12:12-h light-dark cycle environment with ad libitum access to water and the group-specific rat diet. Body weight and food and water intakes were measured daily to monitor the day-to-day health of the rats. Feed efficiency (%) was calculated as follows: [mean body weight gain (g)/daily energy intake (kJ)] ϫ 100 (26) .
The preparation and macronutrient composition of all four diets, including the fatty acid profiles, are described elsewhere (28, 30, 32) . Briefly, the H diet consisted of 175 g of fructose, 395 g of sweetened condensed milk, 200 g of beef tallow, 155 g of powdered rat food, 25 g of Hubble, Mendel-and-Wakeman salt mixture, and 50 g of water per kilogram of diet. In the C diet, fructose and sweetened condensed milk were replaced by the equivalent amount of cornstarch (570 g) and the beef tallow was replaced by equivalent amounts of water (200 g) per kilogram of diet. The chia seed-supplemented diets were prepared by addition of 5% (wt/wt) of the seed replacing an equivalent amount of water in the diet. Chia seed-supplemented diets were administered for 24 wk starting 8 wk after commencement of C or H diet feeding. Drinking water of the H and HC groups was augmented with 25% fructose for the duration of the study.
Cardiovascular measurements. connected to a physiological pressure transducer (model MLT844) using a PowerLab data acquisition unit (ADInstruments, Sydney, Australia), as previously described (32) .
At 32 wk, rats were anesthetized using intraperitoneal Zoletil, as previously described (6, 30) , and echocardiographic examination (Hewlett Packard Sonos 5500, 12-MHz transducer) was performed, in accordance with the guidelines of the American Society of Echocardiography, using the leading-edge method (34) .
Terminal anesthesia was induced via injection of pentobarbitone sodium (Lethabarb, 100 mg/kg ip). Heparin (200 IU; Sigma-Aldrich Australia, Sydney, Australia) was administered through the right femoral vein, and blood (ϳ5 ml) was collected from the abdominal aorta. After blood withdrawal, the rate of pressure increase (ϩdP/dt) and decrease (ϪdP/dt) and the diastolic stiffness constant were assessed using the Langendorff isolated heart preparation, as previously described (5, 30, 32) , with a latex balloon catheter connected to a Capto SP844 MLT844 physiological pressure transducer and Chart software on a Maclab system (ADInstruments Australia and Pacific Islands, Bella Vista, NSW, Australia).
Thoracic aortic rings (ϳ4 mm long) were suspended in an organ bath chamber with a resting tension of ϳ10 mN. Cumulative concentration-response (contraction) curves were measured for norepinephrine (Sigma-Aldrich Australia); concentration-response (relaxation) curves were measured for acetylcholine (Sigma-Aldrich Australia) and sodium nitroprusside (Sigma-Aldrich Australia) in the presence of a submaximal (70%) contraction to norepinephrine (30) .
Oral glucose tolerance and insulin tolerance tests. The oral glucose tolerance test (OGTT) and the insulin tolerance test (ITT) were performed 2 days apart at 32 wk. For the OGTT, basal blood glucose concentrations were measured in blood taken from the tail vein using a Medisense Precision QID glucose meter (Abbott Laboratories, Bedford, MA) after 10 -12 h of overnight food deprivation. The rats were given glucose (2 g/kg body wt) as a 40% solution via oral gavage. Tail vein blood samples were taken at 30, 60, 90, and 120 min following glucose administration.
For the ITT, basal blood glucose concentrations were measured after 4 -5 h of food deprivation, as described above. The rats were injected with insulin-R (0.75 IU/kg ip; Eli Lilly, West Ryde, NSW, Australia), and tail vein blood samples were taken at 30, 60, 90, and 120 min following insulin injections. Rats were withdrawn from the test if the blood glucose concentrations dropped below 1.1 mmol/l, and 4 g/kg glucose solution was immediately administered by oral gavage to prevent hypoglycemia. For the OGTT and ITT, fructosesupplemented drinking water in the H and HC groups was replaced with normal water for the food-deprivation period.
Body composition measurements. A dual-energy X-ray absorptiometer (DXA; model XR36, Norland) was used for DXA measurements on the rats after 32 wk of feeding, 2 days before rats were euthanized for pathophysiological assessments. DXA scans were analyzed using the manufacturer's recommended software for use in laboratory animals (Small Subject Analysis Software, version 2.5.3/ 1.3.1, Norland), as previously described (38) . The precision error of lean mass for replicate measurements with repositioning was 3.2%. Visceral adiposity index (%) was calculated as follows: {[retroperitoneal fat (g) ϩ omental fat (g) ϩ epididymal fat (g)]/body weight (g)} ϫ 100 (17) .
Organ weights. The right ventricle and left ventricle (LV, with septum) were separated after perfusion experiments and weighed. Liver, retroperitoneal fat, epididymal fat, and omental fat were removed following heart removal and blotted dry for weighing. Organ weights were normalized relative to the tibial length at the time of their removal (in mg/mm). Immediately after they were weighed, LV, liver, skeletal muscle, and retroperitoneal fat were stored at Ϫ20°C in 50-ml polypropylene centrifuge tubes for fatty acid analysis.
Fatty acid analysis. Tissue and dietary lipids were extracted by manual solvent extraction using a 2:1 chloroform-methanol mixture with 0.1% butylated hydroxytoluene as an antioxidant, as described in previous studies (16) .
Approximately 15-20 mg of extracted lipid samples, with 1 mg of heptadecanoic acid (C17:0) added as an internal standard, were methylated in a clean 10-ml test tube. Saponified lipids were extracted with 2 ml of heptane and then transferred to an autosampler vial for gas chromatography. Fatty acid methyl esters were analyzed on an Agilent J&W DB-23 column (60 m ϫ 0.25 mm ϫ 0.25 m; Agilent Technologies) by a gas chromatograph (model GC-17A, Shimadzu) equipped with a flame ionization detector. A multiacid standard mixture was used to check the performance of the gas chromatograph and as a recovery test for the sample preparation procedure. Quantitation of the fatty acids in all samples was based on a linear calibration equation obtained from the C17:0 standard. For identification purposes, standard containing a mixture of 28 fatty acid methyl esters (Nu-Check Prep) was used for retention time calibration. A plot of carbon number vs. logarithm of retention time for the saturated series, one degree of unsaturation, and two degrees of unsaturation allowed a relationship to be developed for identification purposes. All fatty acids are expressed as grams per 100 g of total recovered fatty acids. The n-3-to-n-6 ratio was derived using the following formula: (C18: 3n-3 ϩ C20:3n-3 ϩ C20:5n-3 ϩ C22:5n-3 ϩ C22:6n-3)/(C18:2n-6 ϩ C18:3n-6 ϩ C20:2n-6 ϩ C20:3n-6 ϩ C20:4n-6 ϩ C22:2n-6 ϩ C22:4n-6).
Histology. Two rats per group were used exclusively for histological analysis. Two slides were prepared per tissue specimen; two random, nonoverlapping fields per slide were taken to avoid biased analysis. Organs were also collected from rats used for ex vivo studies. Immediately after removal, heart and liver tissues were fixed in 10% neutral buffered formalin for 3 days and then dehydrated and embedded in paraffin wax, as previously described (30) . Thin (7-m) sections of LV and liver were cut and stained with hematoxylin-eosin for determination of inflammatory cell infiltration. Collagen distribution in LV was determined using picrosirius red stain. The extent of collagen deposition in selected tissue sections was determined by laser confocal microscopy (Zeiss LSM 510 upright confocal microscope), with color intensity quantitatively analyzed using ImageJ software (National Institutes of Health) (30) .
Plasma biochemistry. Briefly, blood was centrifuged at 5,000 g for 15 min within 30 min of collection into heparinized tubes. Plasma was separated and transferred to Eppendorf tubes for storage at Ϫ20°C before analysis. Activities of plasma enzymes and analyte concentrations were determined using an Olympus analyser (model AU 400) and kits and controls supplied by Olympus, as previously described (30) .
Statistical analysis. Values are means Ϯ SE. Results were tested for variance using Bartlett's test, and variables that were not normally distributed were transformed (using log 10 function) prior to statistical analyses. Data from C, CC, H, and HC groups were tested by two-way ANOVA. When interaction and/or the main effects were significant, means were compared using Newman-Keuls multiple-comparison post hoc test. Where transformations did not result in normality or constant variance, a Kruskal-Wallis nonparametric test was performed. P Ͻ 0.05 was considered statistically significant. All statistical analyses were performed using Prism version 5.00 for Windows (GraphPad, San Diego, CA).
RESULTS
Dietary intake, body parameters, and plasma biochemistry.
H rats consumed less food than C rats but equivalent volumes of water throughout the 32 wk (Table 1) . Despite the lower food intake, the mean energy intake, feed efficiency, and, therefore, increases in body weight were higher in H than C rats throughout the 32-wk feeding period because of the higher energy density of the H diet (Table 1, Fig. 1A) . Consequently, chronic H diet feeding increased measures of whole body and abdominal adiposity, such as total body fat mass, abdominal circumference, abdominal fat (retroperitoneal, epididymal, and omental), and visceral adiposity index (Table 1, Fig. 1B ). The increase in body weight was the combination of an increase in total body fat mass and a decrease in total body lean mass induced by 32 wk of H diet feeding ( Table 1 ). The bone mineral content was higher in H than C rats (Table 1) .
Chia seed supplementation for 24 wk, starting at 8 wk of the feeding period, increased and maintained a higher water intake in the CC and HC rats but lowered food intake only in the HC rats compared with their respective controls throughout the feeding period (Table 1) . Despite the added dietary energy from chia seed supplementation, the energy intake remained unchanged in CC and HC rats compared with C and H rats, respectively (Table 1) . However, chia seed-supplemented rats showed increased feed efficiency and, therefore, increased body weight compared with C rats (Table 1, Fig.  1A ). These effects were accompanied by increased lean mass in CC and HC rats but increased bone mineral content only in CC rats (Table 1) . Chia seed supplementation did not change whole body adiposity but decreased the visceral adiposity index, abdominal fat, and abdominal circumference (Table 1, Fig. 1B) .
Although H diet feeding for 32 wk did not alter plasma total cholesterol, triglyceride, or nonesterified fatty acid concentrations, chia seed supplementation decreased plasma total cholesterol in CC rats and increased plasma triglycerides in HC rats (Table 1) . H diet feeding increased the lipid content of skeletal muscle, but not heart, liver, or retroperitoneal fat (Table 1) . Chia seed supplementation decreased the lipid content in retroperitoneal fat and increased it in the heart of CC and HC rats, whereas chia seed supplementation decreased the lipid content in skeletal muscle of HC rats (Table 1 ). H diet feeding also decreased the tolerance to exogenous glucose and insulin, and these effects were attenuated by chia seed supplementation (Fig. 2) . The fatty acid profile of the plasma shows that H diet feeding increased the total plasma monounsaturated fatty acids (MUFA; mainly C18:1n-9) without changing the total saturated fatty acids (SFA) and PUFA compared with the C rats ( Table 1) . Chia seed supplementation increased C18:2n-6 and C18:3n-3 and decreased the proinflammatory C20:4n-6 in the plasma (Table 1) .
Cardiovascular structure, function, and fatty acid composition. Compared with C rats, the H diet induced eccentric hypertrophy, characteristic of increased preload, defined as increased LV internal diameter in diastole, without changes in relative wall thickness or end-systolic dimensions (Table 2 ). Consequently, H rats showed impaired systolic function with increased wall stress, increased diastolic stiffness, decreased developed pressure, and decreased dP/dt compared with C rats (Table 2) . However, fractional shortening, ejection time, and ejection fraction were not affected (Table 2) . Additionally, diastolic and stroke volumes and, consequently, cardiac output were elevated in H rats compared with C rats, but heart rate was not affected ( Table 2 ). The ascending and descending aortic pulse wave velocities (V max ) were increased in H rats compared with C rats, suggesting arterial stiffening (Table 2 ). These changes were accompanied by increased estimated LV mass and LV wet weight. H diet feeding also increased systolic blood pressure throughout the 32-wk protocol (Fig. 1C) .
CC and HC rats showed normalized LV volumes and eccentric hypertrophy and, hence, the consequent abnormalities induced by H diet feeding (Table 2) . CC and HC rats showed normalized diastolic stiffness and systolic wall stress. Chia seed supplementation normalized systolic blood pressure after 12 wk of treatment (Fig. 1C) compared with H rats and decreased V max measured at the end of the protocol (Table 2 ).
After 32 wk, H rats showed greater infiltration of inflammatory cells into the LV (Fig. 3C) , as well as increased interstitial collagen deposition (Fig. 3G) , compared with C rats (Fig. 3, A  and E) . Chia seed supplementation normalized inflammatory state (Fig. 3D) and markedly reduced collagen deposition in HC rats (Fig. 3H) . Minimal changes were seen in CC rats (Fig.  3, B and F) . The reduction in LV fibrosis and inflammation was consistent with the reduced diastolic stiffness in HC rats (Fig.  3, D and H, Table 3 ).
Furthermore, H diet feeding diminished endothelium-dependent relaxation to acetylcholine (Fig. 4C ) but did not affect the endothelium-independent relaxation to sodium nitroprusside (Fig. 4B) or the ␣ 1 -adrenoceptor-mediated vascular contraction to norepinephrine in isolated thoracic aortic rings compared with C rats (Fig. 4A) . Although chia seed supplementation did not change ␣ 1 -adrenoceptor responses, it improved endotheliumdependent and -independent relaxation in isolated thoracic aortic rings (Fig. 4) . This effect may contribute to the blood pressure-lowering response to chia seeds.
Similar to the plasma fatty acid profile, H rats showed increases in the proportion of total MUFA compared with C rats but maintained the proportions of SFA and PUFA in the heart (Table 2) . Chia seed supplementation decreased C16:0, C16:1n-7, and C18:1n-9 but increased C18:0 (Table 2) . CC and HC rats accumulated C18:2n-6 and depleted its elongation product, C20:4n-6, and increased elongation products of C18: 3n-3 (C20:5n-3 and C22:6n-3). These results strongly suggest the preferential metabolism of the n-3 PUFA by ⌬ 6 -and ⌬
5
-desaturases, thereby inhibiting the proinflammatory n-6 metabolism pathway.
Hepatic structure, function, and fatty acid composition. H rats showed elevated plasma alanine transaminase and alkaline phosphatase activities compared with C rats (Table 3) . However, aspartate transaminase activity was elevated in the C rats, and plasma lactate dehydrogenase activity and total bilirubin concentration remained unchanged (Table 3) . Chia seed supplementation normalized plasma activities of alanine transam- Fig. 4 . Cumulative concentration-response curves for norepinephrine (A), sodium nitroprusside (B), and acetylcholine (C) in thoracic aortic rings from C, CC, H, and HC groups at 32 weeks. Values are means Ϯ SE; n ϭ 8 -10/group. End-point means without a common lower-case letter in each data set are significantly different.
inase, aspartate transaminase, and lactate dehydrogenase, while alkaline phosphatase activity was increased in HC rats, and CC and HC rats showed reduced plasma bilirubin concentrations (Table 3) . Additionally, H rats showed increased inflammatory cell infiltration (Fig. 5C ) and lipid deposition (Fig. 5G ) compared with C rats (Fig. 5, A and E) . CC (Fig. 5, B and F) and HC (Fig. 5, D and H) rats showed normalized macrovesicular steatosis and portal inflammation.
H diet feeding increased the total MUFA (mainly C18:1n-9) content and decreased the total PUFA (C18:2n-6 and C20: 4n-6) content in liver compared with C rats (Table 3) . Chia seed supplementation decreased the MUFA content and increased C18:2n-6, C18:3n-3, C20:5n-3, C22:5n-3, and C22: 6n-3, consequently increasing the n-3-to-n-6 ratio (Table 3) . C20:4n-6 decreased only in the CC rats (Table 3) .
Adipose tissue and skeletal muscle fatty acid composition. Similar to the fatty acid profile in liver and heart, H diet feeding increased C18:0 and C18:1n-9 and decreased C16:1n-7 and C18:2n-6 content in adipose tissue compared with C rats (Table 4) . Chia seed supplementation decreased C16:0 and C18:0 in HC rats and C16:1n-7 and C18:1n-9 in CC rats. These effects were accompanied by increased proportions of C18: 2n-6 and C18:3n-3 in adipose tissue (Table 4) .
Similarly, the skeletal muscle of H rats had increased proportions of C18:1n-9 and decreased proportions of C18:2n-6 (Table 5) . Chia seed supplementation increased SFA (C16:0 and C18:0) and n-6 fatty acids (C18:2n-6 and C20:4n-6) and decreased C18:1n-9 in skeletal muscle. C18:3n-3, C22:5n-3, and C22:6n-3 were increased in the chia seed-supplemented groups (Table 5) .
DISCUSSION
We have shown that long-term C or H diet feeding in male Wistar rats closely mimics the changes in normal middle-aged humans and the pathophysiology of middle-aged humans with metabolic syndrome, respectively. Compared with our previous studies of young rats fed a C diet for 16 wk (28, 32), chronic C diet feeding for 32 wk induced age-dependent physiological changes without metabolic syndrome, such as disproportionate increases in total body lean and fat mass, reduced bone mineral content, cardiovascular remodeling with increases in systolic blood pressure, LV, and arterial stiffness, and increased plasma markers of liver injury. Compared with C diet feeding, H diet feeding for 32 wk induced increases in visceral adiposity with reduced lean mass, impaired glucose tolerance and insulin sensitivity, and increased LV and arterial stiffening, cardiac fibrosis, hypertension, and hepatic steatosis. These results are consistent with the effects of 16 wk of H diet feeding (28), except 32 wk of H diet feeding additionally induced arterial stiffening and loss of lean mass and increased fat storage typical of the aging process (18) . The cardiovascular remodeling with the H diet aggravates the typical characteristics of a middle-aged human heart. Agedependent structural deterioration of the heart includes LV, as well as cardiomyocyte, hypertrophy, increased collagen deposition, and stiffening of the ventricular wall (15) . The functional manifestation of these changes includes impaired diastolic function without alterations of systolic function, with preserved fractional shortening, ejection fraction, stroke volume, cardiac output, and resting heart rate (15) . In addition to these changes, H diet feeding increased diastolic and stroke volume while maintaining resting heart rate and systolic volume, thereby increasing cardiac output. These increases in diastolic volume and stroke volume are due to the increased preload and consequent eccentric hypertrophy characteristic of H diet feeding (28) .
The shift from young adulthood to middle age is associated with changes in arterial function, such as impaired distensibility with increased V max , a noninvasive clinical measure of aortic stiffness (10, 15) . Age and blood pressure are independently associated with increased V max (10) . However, increased arterial stiffness is not exclusively the result of agedependent deterioration of arterial structure but may also be affected by the endothelial regulation of vascular smooth muscle tone. Aging arteries have increased endothelial permeability and reduced endothelium-dependent relaxation responses to acetylcholine (15, 21) . Consistent with the literature, H diet feeding increased V max , elevated systolic blood pressure, and reduced vasodilator response to acetylcholine in isolated thoracic aorta. However, neither ␣ 1 -adrenoceptor-mediated vascular contraction to norepinephrine nor endotheliumindependent relaxation response to sodium nitroprusside was affected. This suggests that the H diet selectively reduced production or availability of nitric oxide from the endothelium while preserving the contractility of vascular smooth muscle and nitric oxide-mediated vasodilation pathways.
In the absence of the traditional cardiovascular risk factors, obesity and type 2 diabetes are associated with increased arterial stiffness (10, 33) . H diet feeding produced increased whole body and visceral adiposity, with the loss of lean mass and increased accumulation of fat in the skeletal muscle. These effects may have been mediated by reduced skeletal muscle mitochondrial function and generalized decline in muscle protein synthesis with aging (18) .
The loss of muscle mass is coupled with gradual loss of subcutaneous fat after young adulthood (7) . This is where dietary supplementation with chia seed may be an important strategy in improving the quality of life in an aging population. Consistent with our previous report (32), 24 wk of chia seed supplementation attenuated and maintained most structural and functional modifications induced by age or the H diet. More importantly, chia seed supplementation increased whole body lean mass and reduced abdominal fat, but not whole body fat, therefore suggesting lipid redistribution away from the abdominal area. As the total lipid content in major tissues, such as skeletal muscle and liver, decreased or remained unchanged, it is plausible that most of the fat from the viscera was redistributed as subcutaneous fat. Additionally, chia seed supplementation normalized the chronic low-grade inflammation induced by H diet feeding. This effect is most likely caused by the decrease in the proinflammatory n-6 fatty acid metabolism seen as increased precursor (C18:2n-6) and decreased or unchanged product (C20:4n-6), together with increases in the anti-inflammatory fatty acids of the n-3 series (C18:3n-3, C20:5n-3, C22:5n-3, and C22:6n-3) in all tissues. The n-3 series fatty acids have been well studied for their role in maintaining cardiovascular structure and function, as well as reducing the risk factors of metabolic syndrome (31) . Although the high ␣-linolenic acid content may play an important role in mitigating the responses to chronic chia seed supplementation, chia seed is also a rich source of proteins [ϳ25% (wt/wt)] and Values are means Ϯ SE; n ϭ 6 per group. Means within a row with different symbols are significantly different (P Ͻ 0.05).
minerals (mainly calcium and phosphorus) (8) , which may also contribute to some of the observed effects, especially on body composition. More importantly, the response to chia seed supplementation was maintained from our previously reported 16-wk study, and no major adverse effects were observed (32) . In addition, while 8 wk of chia seed supplementation failed to attenuate increased blood pressure as a result of H diet feeding for 16 wk (32), blood pressure was normalized with chronic chia seed supplementation. However, there are striking differences in the handling of SFA, MUFA, and trans fatty acids with both H diet and chia seed supplementation compared with our 16-wk study (32) . We found that 32 wk of C or H diet feeding decreased the net proportion of trans fats, as well as the desaturation index, therefore decreasing MUFA and increasing SFA content compared with our previous study (32) . Also, H diet feeding for 32 wk induced preferential storage of C18:1n-9 over C16:1n-7 as the primary MUFA compared with the C rats. Because of this change in fatty acid content, the stearoyl-CoA desaturase index was normalized with 32 wk of H diet feeding, as the index is calculated as a ratio of C16:0 to C16:1n-7. In contrast to the 16-wk study (32) , chia seed supplementation in this study only affected the n-6 and n-3 PUFA metabolism, and not SFA, MUFA, or trans fatty acids. Since mammals can produce fatty acids up to C18:1 in situ following a series of elongation and desaturation reactions (29) , these results strongly suggest a transition in fatty acid metabolism with age toward increased lipogenesis, as the complete pathway would result in the formation of C18:1n-9 or C16:1n-7 as the final products irrespective of the starting substrate (29) . In heart, liver, and skeletal muscle, the proportions of C18:1n-9 were reduced in rats supplemented with chia seed compared with H rats and remained comparable to or lower than proportions of C18:1n-9 in C rats, suggesting a possible inhibitory role of chia seed in lipogenesis.
These results validate our hypothesis that long-term consumption of the C diet mimics the process of aging, while H diet feeding exacerbates this process, with cardiovascular remodeling, obesity, loss of lean mass, and liver injury. Chia seeds may serve as a complementary dietary strategy to manage age-related morbidity due to the unique lipid redistribution, increased lean mass, and other cardiovascular and hepatic protective responses.
